Evidence map›Paper›PMID 36793876›Full record

ArticleFrontiers in medicine2023

Development process of a clinical guideline to manage type 2 diabetes in adults by Ayurvedic practitioners.

Kaushik Chattopadhyay, Nitin Kapoor, Michael Heinrich, Achintya Mitra, Madhukar Mittal, Sarah Anne Lewis, Sheila Margaret Greenfield, Shyamalendu Mukherjee, Ivo Pischel, Panniyammakal Jeemon and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Editorial: Clinical phytopharmacology.Frontiers in pharmacology · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 3 countries.

Kaushik ChattopadhyayLifespan and Population Health Academic Unit, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
Nitin KapoorDepartment of Endocrinology, Metabolism and Diabetes, Christian Medical College, Vellore, India.
Michael HeinrichCentre for Pharmacognosy and Phytotherapy, School of Pharmacy, University College London, London, United Kingdom.
Achintya MitraCentral Ayurveda Research Institute Under Central Council for Research in Ayurvedic Sciences (Ministry of Ayush), Kolkata, India.
Madhukar MittalDepartment of Endocrinology and Metabolism, All India Institute of Medical Sciences, Jodhpur, India.
Sarah Anne LewisLifespan and Population Health Academic Unit, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
Sheila Margaret GreenfieldInstitute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
Shyamalendu MukherjeeWest Bengal State Medicinal Plants Board, Kolkata, India.
Ivo PischelCentre for Pharmacognosy and Phytotherapy, School of Pharmacy, University College London, London, United Kingdom.
Panniyammakal JeemonSree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India.
Nikhil TandonDepartment of Endocrinology, Metabolism and Diabetes, All India Institute of Medical Sciences, New Delhi, India.
Sanjay KinraDepartment of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Tuhin Kanti BiswasDepartment of Kayachikitsa, J. B. Roy State Ayurvedic Medical College and Hospital, Kolkata, India.
Jo Leonardi-BeeLifespan and Population Health Academic Unit, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
University of Nottingham · GBUniversity College London · GBAll India Institute of Medical Sciences · INAll India Institute of Medical Sciences Jodhpur · INCentral Council for Research in Ayurvedic Science · INChristian Medical College, Vellore · INLondon School of Hygiene & Tropical Medicine · GBMedical College and Hospital, Kolkata · INSree Chitra Thirunal Institute for Medical Sciences and Technology · INUniversity of Birmingham · GB

Funding

Medical Research Council MR/T003537/1Wellcome Trust
6 · The paper itself

Abstract

Background: Type 2 diabetes mellitus (T2DM), a common chronic health condition, has major health and socioeconomic consequences. In the Indian subcontinent, it is a health condition for which individuals commonly consult Ayurvedic (traditional medical system) practitioners and use their medicines. However, to date, a good quality T2DM clinical guideline for Ayurvedic practitioners, grounded on the best available scientific evidence, is not available. Therefore, the study aimed to systematically develop a clinical guideline for Ayurvedic practitioners to manage T2DM in adults. Methods: The development work was guided by the UK's National Institute for Health and Care Excellence (NICE) manual for developing guidelines, the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, and the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument. First, a comprehensive systematic review was conducted which evaluated Ayurvedic medicines' effectiveness and safety in managing T2DM. In addition, the GRADE approach was used for assessing the certainty of the findings. Next, using the GRADE approach, the Evidence-to-Decision framework was developed, and we focused on glycemic control and adverse events. Subsequently, based on the Evidence-to-Decision framework, a Guideline Development Group of 17 international members made recommendations on Ayurvedic medicines' effectiveness and safety in T2DM. These recommendations formed the basis of the clinical guideline, and additional generic content and recommendations were adapted from the T2DM Clinical Knowledge Summaries of the Clarity Informatics (UK). The feedback given by the Guideline Development Group on the draft version was used to amend and finalize the clinical guideline. Results: A clinical guideline for managing T2DM in adults by Ayurvedic practitioners was developed, which focuses on how practitioners can provide appropriate care, education, and support for people with T2DM (and their carers and family). The clinical guideline provides information on T2DM, such as its definition, risk factors, prevalence, prognosis, and complications; how it should be diagnosed and managed through lifestyle changes like diet and physical activity and Ayurvedic medicines; how the acute and chronic complications of T2DM should be detected and managed (including referral to specialists); and advice on topics like driving, work, and fasting including during religious/socio-cultural festivals. Conclusion: We systematically developed a clinical guideline for Ayurvedic practitioners to manage T2DM in adults.

Indexed as

Ayurvedaclinical guidelinedevelopmentmanagementtype 2 diabetes mellitus

Identifiers

PMID36793876
PMCPMC9922832
OpenAlexW4318460696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.